European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience by A.T. van der Ploeg, M.E. Kruijshaar, A. Toscano et al.
ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis by X. Montalban, R. Gold, A.J. Thompson et al.
OnabotulinumtoxinA in chronic migraine: predictors of response. A prospective multicentre descriptive study by C. Domínguez, P. Pozo‐Rosich, M. Torres‐Ferrús et al.
Long-term effects of cognitive rehabilitation on brain, functional outcome and cognition in Parkinson’s disease by M. Díez‐Cirarda, N. Ojeda, J. Peña et al.
European consensus on the concepts and measurement of the pathophysiological neuromuscular responses to passive muscle stretch by C. van den Noort, L. Bar‐On, E. Aertbeliën et al.
Survey of diagnostic and treatment practices for multiple sclerosis in Europe by O. Fernández, M. Delvecchio, G. Eda et al.
Inflammatory profile discriminates clinical subtypes in LRRK2-associated Parkinson’s disease by K. Brockmann, C. Schulte, N. Schneiderhan‐Marra et al.
Impact of intravenous thrombolysis and emergent carotid stenting on reperfusion and clinical outcomes in patients with acute stroke with tandem lesion treated with thrombectomy: a collaborative pooled analysis by B. Gory, D.C. Haussen, M. Piotin et al.
European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain F-18-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus by F. Nobili, J. Arbizu, F. Bouwman et al.
Paediatric acute disseminated encephalomyelitis followed by optic neuritis: disease course, treatment response and outcome by Y.Y.M. Wong, Y. Hacohen, T. Armangue et al.
European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience by A.T. van der Ploeg, M.E. Kruijshaar, A. Toscano et al.
ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis by X. Montalban, R. Gold, A.J. Thompson et al.
OnabotulinumtoxinA in chronic migraine: predictors of response. A prospective multicentre descriptive study by C. Domínguez, P. Pozo‐Rosich, M. Torres‐Ferrús et al
Long-term effects of cognitive rehabilitation on brain, functional outcome and cognition in Parkinson’s disease by M. Díez‐Cirarda, N. Ojeda, J. Peña et al.
European consensus on the concepts and measurement of the pathophysiological neuromuscular responses to passive muscle stretch by C. van den Noort, L. Bar‐On, E. Aertbeliën et al.
Survey of diagnostic and treatment practices for multiple sclerosis in Europe by O. Fernández, M. Delvecchio, G. Eda et al.
Inflammatory profile discriminates clinical subtypes in LRRK2-associated Parkinson’s diseaseby K. Brockmann, C. Schulte, N. Schneiderhan‐Marra et al.
Impact of intravenous thrombolysis and emergent carotid stenting on reperfusion and clinical outcomes in patients with acute stroke with tandem lesion treated with thrombectomy: a collaborative pooled analysis by B. Gory, D.C. Haussen, M. Piotin et al.
European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain F-18-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus by F. Nobili, J. Arbizu, F. Bouwman et al.
Paediatric acute disseminated encephalomyelitis followed by optic neuritis: disease course, treatment response and outcome by Y.Y.M. Wong, Y. Hacohen, T. Armangue et al.
